News
A new facility at the Australian Institute for Bioengineering and Nanotechnology is set to provide researchers with cancer vaccines tailored to individual patients.
A new nanodevice designed by AIBN researchers analyses sugars on the surface of cellular messenger particles to catch early signs of lung cancer.
Join The Network
Stay on top of our industry news and developments, events and opportunities, by joining The Network
Meet our researchers
Read nowFollow us
Features
Professor Lianzhou Wang has been named UQ's first ever ARC Industry Laureate Fellow, winning $3.6 million to help position Australia as a leading supplier of superior batteries for electric vehicles.
Work on a new range of hyper accurate cancer drugs has begun with the launch of an Australian-first research and manufacturing hub.
Partner with us
Contact us and learn how our scientific expertise and cutting edge facilities could help you reach your goals.
